"The current Directors collectively possess an effective blend of expertise in fund raising, investment portfolio
management and executive management, and intend to focus on delivering initiatives designed to ultimately
enhance shareholder value which, in the Board’s view, is not presently reflected in the Company’s current market
capitalisation
After a period of relative inactivity during the year, during which Bisan focused on assessing its options and
determining forward strategies, the Company underwent a number of strategic changes levelled at
generating value for shareholders.
Directors collectively were paid their annual remuneration of $464,788 in cash."
BSN Price at posting:
0.4¢ Sentiment: None Disclosure: Held
